Is Inari Medical Inc (NASDAQ: NARI) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

NARI belongs to the Healthcare sector of the NASDAQ while operating in the Medical Devices industry. The current market capitalization of Inari Medical Inc is $4.67B. A total of 0.99 million shares were traded on the day, compared to an average of 2.21M shares.

In the most recent transaction, Hoffman William sold 200,000 shares of NARI for 60.47 per share on Jan 06 ’25. After the transaction, the Director now owns 238,987 company shares. In a previous transaction on Jan 06 ’25, WILLIAM HOFFMAN bought 200,000 shares at 49.77 per share.

Among the insiders who sold shares, Hykes Andrew disposed of 3,000 shares on Dec 20 ’24 at a per-share price of $55.29. This resulted in the President and CEO holding 439,310 shares of NARI after the transaction. In another insider transaction, Hoffman William sold 60,000 shares at $55.66 per share on Dec 16 ’24. Company shares held by the Director now total 441,233.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NARI has a high of $79.76 and a low of $36.73.

As of this writing, NARI has an earnings estimate of -$0.04 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of $0.03 per share and a lower estimate of -$0.24.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NARI’s latest balance sheet shows that the firm has $176.10M in Cash & Short Term Investments as of fiscal 2021. There were $29.21M in debt and $42.51M in liabilities at the time. Its Book Value Per Share was $7.44, while its Total Shareholder’s Equity was $239.21M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NARI is Buy with a score of 3.00.

Most Popular

Related Posts